BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20210101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220421
DTEND;VALUE=DATE:20220701
DTSTAMP:20260516T020253
CREATED:20220425T094247Z
LAST-MODIFIED:20220519T120013Z
UID:33903-1650499200-1656633599@www.pharmajournalist.com
SUMMARY:CPhI & P-MEC China Virtual Expo Connect
DESCRIPTION:This year CPhI & P-MEC China returns as a SMART event\, combining 2 months of online event with a 3-day in-person event to help you connect for an extended period. \n \n“Virtual Expo Connect”\, to be held from 21st April – 30th June 2022\, is the digital extension of the physical CPhI & P-MEC China event that offers an online alternative for global pharma professionals. \nPowered by PharmaSources.com\, Virtual Expo Connect builds the online platform adding valued services and infinite opportunities to connect\, learn\, trade and grow. \nTo know more visit: https://www.pharmasources.com/vec2022
URL:https://www.pharmajournalist.com/event/cphi-p-mec-china-virtual-expo-connect-2/
LOCATION:Online
ORGANIZER;CN="Informa Markets":MAILTO:Yingqi.shi@imsinoexpo.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220524
DTEND;VALUE=DATE:20220526
DTSTAMP:20260516T020253
CREATED:20220105T113225Z
LAST-MODIFIED:20220105T113225Z
UID:32657-1653350400-1653523199@www.pharmajournalist.com
SUMMARY:Customer Engagement Europe 2022
DESCRIPTION:Deliver enduring behavioral change with agile\, personalized engagement  \nPrecise\, Personalized and Proactive- the future of customer engagement is a digitally enabled\, hybrid omnichannel strategy.   \nHeard that all before?     \nFrom measuring clicks to measuring behaviour change\, the way we think about customer preference has forever been changed. Across marketing\, commercial\, and medical\, the skills we need to deliver on changing HCP expectations are aligning. Now is the time to do the same for our strategy.   \nReuters Events Pharma: Customer Engagement Europe 2022 (London\, May 24-25) is the only pharma event bringing together functions to drive the future of agile engagement. Join us to deliver a hybrid\, insight driven\, modularized model that incorporates iterative insights\, delves deeper into data\, empowers our field forces with digital empathy\, prioritizes innovation\, and equips our teams for industry leadership.   \nTo know more visit: https://events.reutersevents.com/pharma/customer-engagement-europe
URL:https://www.pharmajournalist.com/event/customer-engagement-europe-2022/
LOCATION:Hilton Tower Bridge\, London 5 More London Riverside\, Tooley St\, London\, SE1 2BY\, United Kingdom
ORGANIZER;CN="Reuters Events":MAILTO:saskia.burbach@thomsonreuters.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220524
DTEND;VALUE=DATE:20220526
DTSTAMP:20260516T020253
CREATED:20220117T091118Z
LAST-MODIFIED:20220117T091118Z
UID:32827-1653350400-1653523199@www.pharmajournalist.com
SUMMARY:Customer Engagement Europe 2022
DESCRIPTION:Precise\, Personalized and Proactive- the future of customer engagement is a digitally enabled\, hybrid omnichannel strategy. \nHeard that all before? \n \nFrom measuring clicks to measuring behaviour change\, the way we think about customer preference has forever been changed. Across marketing\, commercial\, and medical\, the skills we need to deliver on changing HCP expectations are aligning. Now is the time to do the same for our strategy.   \nReuters Events Pharma: Customer Engagement Europe 2022 (London\, May 24-25) is the only pharma event bringing together functions to drive the future of agile engagement. Join us to deliver a hybrid\, insight driven\, modularized model that incorporates iterative insights\, delves deeper into data\, empowers our field forces with digital empathy\, prioritizes innovation\, and equips our teams for industry leadership.   \nTo know more visit: https://bit.ly/3qz6d9B
URL:https://www.pharmajournalist.com/event/customer-engagement-europe-2022-2/
LOCATION:Hilton Tower Bridge\, London 5 More London Riverside\, Tooley St\, London\, SE1 2BY\, United Kingdom
ORGANIZER;CN="Reuters Events":MAILTO:saskia.burbach@thomsonreuters.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220524
DTEND;VALUE=DATE:20220527
DTSTAMP:20260516T020253
CREATED:20220125T090934Z
LAST-MODIFIED:20220125T114614Z
UID:32936-1653350400-1653609599@www.pharmajournalist.com
SUMMARY:Next Generation RNA Therapeutics Summit
DESCRIPTION:With novel RNA-based modalities having seen extraordinary development in the last 18 months\, there has never been a more important time for the RNA community to unite\, share learnings and accelerate the field towards successful proof of concept and effective therapeutic development. \nStay ahead of the curve with novel RNA therapeutics and vaccines that offer exceptional stability and durability whilst addressing key delivery\, pharmacology and scalability challenges to successfully translate safe and effective next generation RNA therapeutics into the clinic. \nThe Next Generation RNA Therapeutics Summit is the only meeting to deep dive into the specific challenges and opportunities associated with novel RNA modalities\, welcoming cutting-edge biotech giants such as Pfizer\, BioNTech\, Moderna Therapeutics and Replicate Bioscience to share unmissable insights on circular RNA\, tRNA and self-amplifying RNA therapeutics and vaccines. \nJoin 80+ thought leaders under one roof as they set the scene for next generation RNA therapeutics. This unique group of Directors\, Heads and VPs of RNA Therapeutics\, Chemistry\, Delivery and New Therapeutics will unite at this must-attend event for the RNA community. Don’t miss out! \nTo find out more\, visit: https://ter.li/0ei6ql
URL:https://www.pharmajournalist.com/event/next-generation-rna-therapeutics-summit/
LOCATION:Omni Parker House\, 60 School St\, Boston\, MA\, 02108\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220524
DTEND;VALUE=DATE:20220527
DTSTAMP:20260516T020253
CREATED:20220207T101226Z
LAST-MODIFIED:20220207T101226Z
UID:33175-1653350400-1653609599@www.pharmajournalist.com
SUMMARY:4th Annual Cell Engager Summit
DESCRIPTION:4th Annual Cell Engager Summit  May 24-26\, 2022 | Boston\, MA \n\nThe 4th Annual Cell Engager Summit returns to bring you the latest on effectively targeting lymphocyte-restricted tumor-associated antigens to treat hematological malignancies\, including CD19\, CD20\, BCMA\, CD33\, and CD123. \n \nThis must-attend meeting will provide a comprehensive understanding of the development of multi-specific cell engaging therapeutics in liquid and solid tumor indications\, with the goal of bringing early-stage innovation to the clinic. \nLearn all there is to know about the immune cell engager landscape\, including clinical achievements\, potential response predictors\, and novel immune cell-based engager therapeutic discoveries. \nYou will leave this meeting with key steps to improving safety and efficacy in the solid tumor microenvironment through lower CRS\, greater dose\, and lower TMDD by targeting tumor antigens such as HER2 and EGFR\, and modifying co-stimulatory receptors (for example CD137/4-1BB\, CD28). \nEnsure your Cell Engager program reaches full clinical potential through learning from the pioneers of immunotherapy. \nTo know more visit: https://ter.li/d3i1x0
URL:https://www.pharmajournalist.com/event/4th-annual-cell-engager-summit/
LOCATION:Boston Park Plaza\, 50 Park Plaza\, Boston\, MA\, 02116\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220524
DTEND;VALUE=DATE:20220527
DTSTAMP:20260516T020253
CREATED:20220405T114748Z
LAST-MODIFIED:20220406T094813Z
UID:33731-1653350400-1653609599@www.pharmajournalist.com
SUMMARY:Hippo Pathway Targeted Drug Development Summit
DESCRIPTION:It has long been understood that the Hippo pathway plays a critical role in the development of a wide range of diseases. Although once seen as an elusive pathway\, emerging novel data and research is forging a wider and more developed mechanistic understanding of it. New avenues have been opened to evolve the landscape of targetable nodes and therapeutic interventions\, from small molecule approaches to novel modalities targeting the TEAD transcription complex. \nWith the clear therapeutic potential of this highly attractive and targetable pathway\, investment\, collaboration\, and interest has flooded in through biopharma and academia – and what was once an unexploited space is now seeing an abundance of promising therapeutic interventions. \nThe inaugural Hippo Pathway Targeted Drug Development Summit has been established as the first and only industry dedicated forum focused on accelerating the mechanistic understanding and potential of the Hippo signaling pathway to enhance the discovery\, translation\, and clinical development of safe and effective drugs in oncology\, regenerative medicine and beyond. \nUniting the leading minds of large pharma\, biotech and academia\, this unrivalled conference will showcase the pioneering discoveries\, critical novel findings and promising clinical candidates drugging YAP\, TAZ & TEAD transcription factors and other high-value targets within the Hippo pathway. With Keynote sessions from Ikena Oncology\, Spring Works Therapeutics\, Cedilla and Vivace Therapeutics\, this is a unique opportunity to hear first-hand the development of novel YAP/TAZ-TEAD antagonists\, from discovery to the clinic. \nOver 80 key stakeholders from BridgeBio\, Cancer Research UK\, AstraZeneca\, Orion Pharma\, Faze Medicines\, Inventiva\, Zentalis Pharmaceuticals\, Basilea Pharmaceuticals and many more have already confirmed their places as the industry continues to unlock critical pieces of the puzzle in the understanding and exploitation of this signaling pathway. \nTogether\, we will unite to learn\, debate\, and discuss; leverage the therapeutic opportunity of this pathway; and critically address the huge unmet clinical need. \nTo know more visit: https://ter.li/4tdp3b
URL:https://www.pharmajournalist.com/event/hippo-pathway-targeted-drug-development-summit/
LOCATION:DoubleTree Suites by Hilton Hotel Boston\, 400 Soldiers Field Road\, Cambridge\, Boston\, MA\, 02134\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
END:VCALENDAR